Innealta Capital’s SI-BONE Inc SIBN Stock Holding History

Innealta Capital’s Portfolio SIBN Stock Details SIBN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-32	Closed	-$414	–	1425
2024 Q2	$414	Buy	+32	New	+$457	﹤0.01%	1505

Other funds holding SIBN

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Innealta Capital's SIBN Position: Q3 2024 in Review

Innealta Capital sold out of SI-BONE Inc (SIBN) in Q3 2024, closing a stake of 32 shares — an estimated $414 sold.

Innealta Capital first reported a position in SIBN in Q2 2024 and held it in 1 quarter. The position peaked at $414 in Q2 2024. 133 funds tracked by Wall St. Rank hold SIBN as of Q3 2024.

Innealta Capital reported no remaining SI-BONE Inc position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 32 SI-BONE Inc shares in Q3 2024, an estimated $414.
Innealta Capital first reported a position in SI-BONE Inc in Q2 2024 and held it in 1 quarter.
Innealta Capital's SI-BONE Inc position peaked at $414 in Q2 2024.
133 funds tracked by Wall St. Rank held SI-BONE Inc as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.